Radiographically quantified sarcopenia and traditional cardiovascular risk assessment in predicting long-term mortality after endovascular aortic repair

Paajanen, Paavo; Lindström, Iisa; Oksala, Niku; Väärämäki, Suvi; Saari, Petri; Mäkinen, Kimmo; Kärkkäinen, Jussi M.

doi:10.1016/j.jvs.2022.03.859

Cited by 9 publications

(7 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most studies were conducted in community-dwelling settings [ 22 – 24 , 28 , 30 , 31 , 35 , 36 , 38 – 40 , 42 , 45 – 49 , 54 ]. Seven studies included patients with acute diseases (hospital-setting) [ 26 , 27 , 33 , 37 , 50 – 52 ], while four studies included patients with chronic conditions (out-patient setting) [ 25 , 32 , 41 , 44 ], and one study including nursing-home residents [ 34 ]. In terms of study design, most of the studies were observation studies with a cross-sectional or longitudinal design ( 22 – 31 , 33 , 34 , 36 – 39 – 45 , 46 – 54 ), while three studies [ 32 , 35 , 46 ] applied interventions.…”

Section: Resultsmentioning

confidence: 99%

“…In most studies sarcopenia was defined according to the criteria set by the European Working Group on Sarcopenia in Older People in the updated version from 2019 (EWGSOP2) ( n = 15) or the original version from 2010 (EWGSOP) ( n = 14). However, in some studies multiple criteria such as EWGSOP, EWGSOP2, and National Institutes of Health Sarcopenia Project definition (FNIH) were applied [ 27 , 39 , 43 ], and in other studies alternative criteria were used [ 26 , 33 , 35 , 45 , 57 ].…”

Section: Resultsmentioning

confidence: 99%

“…Different assessment methods of muscle mass including Dual energy X-ray absorptiometry (DXA) [ 22 , 24 , 25 , 27 , 29 , 30 , 32 , 33 , 38 – 41 , 45 – 47 , 52 – 54 ], Bioelectrical Impedance Analysis (BIA) [ 28 , 31 , 34 , 44 , 48 , 49 ], Bioimpedance Spectroscopy (BIS) [ 35 , 42 , 43 ], Computed Tomography (CT) [ 33 ], and Computed Tomography Angiogram (CTA) [ 26 ] were used in the included studies.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review

Baygi,

Buhl,

Thilsing

et al. 2024

BMC Geriatr

View full text Add to dashboard Cite

Background Sarcopenia and sarcopenic obesity (SO) are age-related syndromes that may compromise physical and mental health among older adults. The Nordic countries differ from other regions on prevalence of disease, life-style behavior, and life expectancy, which may impact prevalence of sarcopenia and SO. Therefore, the aim of this study is to review the available evidence and gaps within this field in the Nordic countries. Methods PubMed, Embase, and Web of science (WOS) were searched up to February 2023. In addition, grey literature and reference lists of included studies were searched. Two independent researcher assessed papers and extracted data. Results Thirty-three studies out of 6,363 searched studies were included in this scoping review. Overall prevalence of sarcopenia varied from 0.9 to 58.5%. A wide prevalence range was still present for community-dwelling older adults when definition criteria and setting were considered. The prevalence of SO ranged from 4 to 11%, according to the only study on this field. Based on the included studies, potential risk factors for sarcopenia include malnutrition, low physical activity, specific diseases (e.g., diabetes), inflammation, polypharmacy, and aging, whereas increased levels of physical activity and improved dietary intake may reduce the risk of sarcopenia. The few available interventions for sarcopenia were mainly focused on resistance training with/without nutritional supplements (e.g., protein, vitamin D). Conclusion The findings of our study revealed inadequate research on SO but an increasing trend in the number of studies on sarcopenia. However, most of the included studies had descriptive cross-sectional design, small sample size, and applied different diagnostic criteria. Therefore, larger well-designed cohort studies that adhere to uniform recent guidelines are required to capture a full picture of these two age-related medical conditions in Nordic countries, and plan for prevention/treatment accordingly.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review

Baygi,

Buhl,

Thilsing

et al. 2024

BMC Geriatr

View full text Add to dashboard Cite

show abstract

“…This method had been previously tested and described to be applicable by a single clinician in a routine clinical setting [ 20 ]. To define possible sarcopenia we used a PMA of under 800 mm 2 for males and under 550 mm 2 for females as a cut-off based on an earlier Finnish study [ 21 ].…”

Section: Methodsmentioning

confidence: 99%

Osteoporosis and sarcopenia are common and insufficiently diagnosed among chronic pancreatitis patients

et al. 2023

View full text Add to dashboard Cite

Purpose Chronic pancreatitis (CP) leads to diabetes and pancreatic exocrine insufficiency (PEI). PEI may lead to maldigestion and malnutrition, which may cause fat-soluble vitamin deficiency, sarcopenia and abnormal bone density. We aim to study the prevalence of osteoporosis, sarcopenia and vitamin deficiency among CP patients. Methods Long-term (4–5 years) follow-up was implemented on CP patients. We recorded CP duration, BMI, smoking, alcohol consumption and medication. We determined the serum values for A, D and E vitamins, albumin, creatinine, haemoglobin, calcium and magnesium. Bone density measurement was taken from the proximal femur and lumbar spine. CT/MRI scans were used to measure for psoas muscle area. Results A total of 33 patients (median age 62 [39–81] years, 61% male) were included. None of these patients had earlier diagnosis of osteopathy, and none of them had known vitamin deficiency or were sarcopenic. Nineteen patients (57%) had pancreatic exocrine insufficiency and of these seven patients (37%) had no pancreatic enzyme replacement therapy (PERT) and one (5%) had inadequate enzyme therapy. During the study, osteoporosis was diagnosed in 20% and possible sarcopenia in 48% of patients. PEI and inadequate PERT was associated with low E vitamin levels (75% vs. 0%, p = 0.012), higher risk of osteoporosis (43% vs. 5.6%, p = 0.013) and sarcopenia (80% vs. 36%, p = 0.044). Conclusion This study demonstrates that chronic pancreatitis is associated with osteoporosis, sarcopenia and vitamin deficiency. If untreated, pancreatic exocrine insufficiency is associated with increased risk of these outcomes. This highlights the importance of identifying and treating PEI in CP patients.

show abstract

“… 3 , 5 ASA class has contributed to outcomes at 30 and 90 days. 6 , 7 In endovascular repair of abdominal aortic aneurysms, the ASA classification is less predictive but, when combined with the psoas muscle area, could be useful, 7 although this has not been independently and unequivocally borne out. 2 , 8 , 9 …”

mentioning

confidence: 99%

Physiologic risk stratification is important to long-term mortality, complications, and readmission in thoracic endovascular aortic repair

Bhamidipati

Tohill

Robe

et al. 2023

Journal of Vascular Surgery Cases, Innovations and Techniques

View full text Add to dashboard Cite

Radiographically quantified sarcopenia and traditional cardiovascular risk assessment in predicting long-term mortality after endovascular aortic repair

Cited by 9 publications

References 25 publications

Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review

Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review

Osteoporosis and sarcopenia are common and insufficiently diagnosed among chronic pancreatitis patients

Physiologic risk stratification is important to long-term mortality, complications, and readmission in thoracic endovascular aortic repair

Contact Info

Product

Resources

About